| Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ... Nature 593 (7858), 266-269, 2021 | 1252 | 2021 |
| Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1169 | 2021 |
| Antibody status and incidence of SARS-CoV-2 infection in health care workers SF Lumley, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ... New England Journal of Medicine 384 (6), 533-540, 2021 | 1070 | 2021 |
| SARS-CoV-2 evolution during treatment of chronic infection SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ... Nature 592 (7853), 277-282, 2021 | 1045 | 2021 |
| Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study TM Walker, CLC Ip, RH Harrell, JT Evans, G Kapatai, MJ Dedicoat, ... The Lancet infectious diseases 13 (2), 137-146, 2013 | 1003 | 2013 |
| Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 937 | 2022 |
| COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study VJ Hall, S Foulkes, A Saei, N Andrews, B Oguti, A Charlett, E Wellington, ... The Lancet 397 (10286), 1725-1735, 2021 | 804 | 2021 |
| Diverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing DW Eyre, ML Cule, DJ Wilson, D Griffiths, A Vaughan, L O'Connor, CLC Ip, ... New England Journal of Medicine 369 (13), 1195-1205, 2013 | 761 | 2013 |
| Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... Nature 593 (7857), 136-141, 2021 | 752 | 2021 |
| SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) VJ Hall, S Foulkes, A Charlett, A Atti, EJM Monk, R Simmons, E Wellington, ... The Lancet 397 (10283), 1459-1469, 2021 | 715 | 2021 |
| Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK KB Pouwels, E Pritchard, PC Matthews, N Stoesser, DW Eyre, KD Vihta, ... Nature medicine 27 (12), 2127-2135, 2021 | 676 | 2021 |
| Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study TM Walker, TA Kohl, SV Omar, J Hedge, CDO Elias, P Bradley, Z Iqbal, ... The Lancet infectious diseases 15 (10), 1193-1202, 2015 | 650 | 2015 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 490* | 2022 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 479 | 2021 |
| Effect of Covid-19 vaccination on transmission of alpha and delta variants DW Eyre, D Taylor, M Purver, D Chapman, T Fowler, KB Pouwels, ... New England Journal of Medicine 386 (8), 744-756, 2022 | 477 | 2022 |
| A Candida auris Outbreak and Its Control in an Intensive Care Setting DW Eyre, AE Sheppard, H Madder, I Moir, R Moroney, TP Quan, ... New England Journal of Medicine 379 (14), 1322-1331, 2018 | 472 | 2018 |
| Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom E Pritchard, PC Matthews, N Stoesser, DW Eyre, O Gethings, KD Vihta, ... Nature medicine 27 (8), 1370-1378, 2021 | 395 | 2021 |
| Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 365 | 2021 |
| SARS-CoV-2 within-host diversity and transmission KA Lythgoe, M Hall, L Ferretti, M de Cesare, G MacIntyre-Cockett, ... Science 372 (6539), eabg0821, 2021 | 358 | 2021 |
| Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018 DW Eyre, ND Sanderson, E Lord, N Regisford-Reimmer, K Chau, ... Eurosurveillance 23 (27), 1800323, 2018 | 352 | 2018 |
Sarah WalkerProfessor of Medical Statistics and Epidemiology, Oxford University and University College LondonOverená e-mailová adresa na: ndm.ox.ac.uk
